Dementia 2025_ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Scientific Programs coming soon..
Scientific Programs coming soon..
Important Alert:
X Please be aware of fraudulent communication claiming to collect conference fees through unauthorized means, including cloned email addresses and phone numbers. Magnus Group advises all attendees to only process payments through our official event website and report any suspicious activity to contact@magnusgroup.org
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Alzheimer’s disease (AD) affects one in ten people over the age of 65, one in two over age 85. There are today 55 million people with AD worldwide. The largest increase in the number of people suffering with AD between now and 2050 will be in the developing world and any ne [....] » Read More
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
The House of Commons Inequalities in Dementia Care Debate 2024 highlighted that in the whole of the UK, the number of people with dementia is estimated at 850,000 and in England, around 540,000 people care for an individual with dementia. These numbers are replicated around the w [....] » Read More
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Choosing the endpoint of analysis of treatment efficacy determines the size of treatment effect. Effect size calculation of composite endpoints cannot be used for analysing treatment efficacy as it is distorted by the interaction of instrument and severity of disease Decline [....] » Read More
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Alzheimer disease (AD) is a devasting problem for the aging population with less than 2% of cases are due to mutations on presenilins or Alzheimer Precursor Protein (APP). At the biochmical level, AD is characterized by senile plaques due to aggregation of amyloid peptides from t [....] » Read More
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Objective: To investigate quality of life in children with autism spectrum disorder.This study aimed to evaluate the validity of existing QoLquestionnaires for use with children with ASD aged 8–12 years. Method 200 children with autism spectrum disorder (male: 118, female: [....] » Read More
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of
Transcranial photobiomodulation (t-PBM) is a novel, non-invasive, neuromodulation technique. It has a wide range of indications in neurodegenerative diseases including mild cognitive impairment (MCI), which serves as a potential preclinical stage of early Alzheimer’s diseas [....] » Read More
Title : Associative memory cells in physiology and pathology
Jin Hui Wang, University of Chinese Academy of Sciences, China
Associative memory occurs daily basis in lifespan, in which the basic units in memory traces have been found as associative memory cells that are critical for cognitive activities and emotion responses. In addition to encoding the physiological signals, these associative memory c [....] » Read More
Title : New vision for early detection of alzheimer's disease
Sharmistha Dey, All India Institute of Medical Sciences, India
Background: Recent research on Alzheimer’s disease (AD) has highlighted that the oxidative damage is the earliest event of disease. These oxidative modifications are closely associated with inflammatory molecules. It is necessary to explore these two pathways with AD pathop [....] » Read More
Title : The vital role of care homes in supporting individuals with neurological conditions
Akankunda Veronicah, Golden Age Elderly Homes Kampala, Uganda
Care homes play a crucial role in providing specialized care and support to individuals with neurological conditions such as Alzheimer's disease, Parkinson's disease, and stroke survivors. These facilities offer a safe and structured environment, tailored to meet the uniq [....] » Read More
Title : Electrophysiology and alzheimer's pathology: A scoping review on EEG correlations with CSF biomarkers
Charikleia Karastamati, University of Pavia, Italy
The increasing prevalence of Alzheimer’s Disease (AD) necessitates effective diagnostic strategies for early intervention. This presentation examines the relationship between electroencephalography (EEG) and cerebrospinal fluid (CSF) biomarkers, highlighting their combined [....] » Read More
Title : Semantic-based memory-encoding strategy in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised
Karen P Y Liu, Western Sydney University, Hong Kong
Background and Aims: Nearly 20% of adults over 65 years old are affected by mild cognitive impairment and up to 70% of these will go on to develop a type of dementia. There is a strong need for further research into early intervention strategies to delay the impact of cognitive d [....] » Read More
Title : Association between the triglyceride glucose-body mass index and memory-related diseases: A nationwide cohort study
Kanran Wang, Chongqing University Cancer Hospital, Chile
Background: This study aimed to examine the longitudinal association between the triglyceride glucose-body mass index (TyG-BMI) index and memory-related diseases (MDs) among Chinese adults. Methods: Data were obtained from the China Health and Retirement Longitudinal Study (CH [....] » Read More
Title : Validation study of the cogniscan computerized test for memory and processing speed in a Brazilian sample
Mariana Medeiros Assed, University of Sao Paulo, Brazil
Objective: To evaluate the psychometric properties of the Cogniscan screening test, a self-administered software for assessing episodic and working memory, focusing on validating its accuracy in a Brazilian clinical sample. Participants. Methods: This study involves 300 volunt [....] » Read More
Title : Alzheimer’s Disease (AD) with preexisting hypofrontality versus frontal AD: radiologic and neuropsychological data in a case of likely dysexecutive alzheimer’s disease in a patient with schizophrenia
James S Maniscalco, Northwell Health Staten Island University Hospital, United States
Frontal Alzheimer’s disease (fAD) is an atypical AD variant which is difficult to differentiate from and frequently misdiagnosed as behavioural variant frontotemporal dementia (bvFTD). Most recent work has identified two subtypes of fAD: a behavioural subtype (bAD) associat [....] » Read More
Title : Effects of dementia on incident Post-COVID Conditions (PCC) in patients with SARS-COV-2 (COVID-19)
Nicholas Kendrick, Kaiser Permanente Mid Atlantic Permanente Medical Group, United States
Dementia is associated with a heightened acute response to SARS-CoV-2, but limited data exist on Post-COVID Conditions (PCC) in people with dementia (PWD). This retrospective study assessed PCC incidence in PWD compared to people without dementia (PWoD) within Kaiser Permanente M [....] » Read More